top of page

Creating a
and productive future for biotech.


Scaling adherent cell yields in minimal space

three 96-well plates on green background, one transparent, one black and one white

The world’s first
plant-based 96-well plates

Maximized growth surface, minimal footprint

The CellScrew®s compact design combines a large growth surface for adherent cell cultivation on the small footprint of just one bottle. One CellScrew® 10K can replace up to twelve standard roller bottles (850 cm²).

Frame 4(1).png

Our Mission

Being the world's first company that produces labware from plant-based plastic, we empower the biopharmaceutical industry to embrace sustainability. Through pioneering systems like the CellScrew®, we aim to address the bottleneck in biopharmaceutical production by enhancing production capacity, ultimately increasing patient access and affordability to life-changing novel therapies.

Sustainability in the healthcare sector

With a total amount of two gigatons of carbon dioxide equivalent, the global healthcare sector is responsible for 4,4 % of global carbon emissions. By replacing non-renewable plastic with plant-based plastic, we provide the industry with an efficient tool to take action in reducing its climate impact.

Automation in bioprocessing

We develop systems that drive the automation of adherent cell culture.

In the growing field of cell and gene therapies, there is a pressing demand for automated solutions that can streamline and expedite processes, particularly because the development of these innovative therapies relies on small batch sizes. In a growing market, where skilled personnel is limited, automation is key to successful scale-up.

Affordability & accessibility of treatments

Innovative systems like CellScrew® increase the accessibility and affordability of the most advanced therapies for patients.
By increasing efficiency and reducing costs, patients will benefit. Not only will therapies become more affordable, but they will also be available faster as the time to market can be shortened.

Replace non-renewable plastics
plant-based PLA.

You can be part of the transformation of the biotechnology sector by using laboratory consumables made of polylactic acid (PLA), a plant-based biopolymer produced entirely from renewable crops. Learn more about the material and its applications.


Illustration of the material cycle of PLA: 
1. CO2 absorption during corn growth
2. fermentation
3. production 
4. use in the Product CellScrew
5. waste incineration 
5. emission of CO2
Illustration of the material cycle of polystyrene: 
1. crude oil
2. fermentation
4. use in tub stacking systems
5. waste incineration 
5. emission of CO2


You might know us from ...

Logo Founders League
Logo Laborjournal
Logo Frankfurter Rundschau

About Green Elephant Biotech

Green Elephant was founded in 2021 by Dr. Joel Eichmann and Felix Wollenhaupt. Since then, we have been joined by diverse team members from backgrounds in bioprocessing, business development, and marketing. Together, we strive to provide innovative solutions for today’s challenges faced by the biopharmaceutical and biotechnology industries.

The Green Elephant team

Don’t miss any product updates - subscribe to our newsletter
You can unsubscribe at any time

Thanks for subscribing to our newsletter.

bottom of page